跳到主要导航
跳到搜索
跳到主要内容
Pure University (For Demo Only) 国内
帮助和常见问题
English
中文
国内
简介
研究单位
科研成果
设备
数据集
活动
奖项
影响
项目
新闻 / 媒体
按专业知识、名称或附属进行搜索
联系专家
查看 Scopus 资料
Camfield Carol S.
Assistant Professor
Dalhousie University
,
Atelier Future
电子邮件
CC971900
dal
ca
网站
https://www.scopus.com/authid/detail.url?authorId=35413971900
h-index
h10-index
h5-index
13096
引用
64
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
752
引用
13
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
29
引用
3
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
1977 …
2021
每年的科研成果
综述
指纹
网络
科研成果
(241)
新闻 / 媒体
(1)
相似简介
(6)
指纹
深入其中 Camfield Carol S. 为活跃的研究主题。这些主题标签来自此人的成果。它们共同形成唯一的指纹。
分类
加权
按字母排序
Medicine and Dentistry
Epileptic Seizure
100%
Anticonvulsant
33%
Pediatrics
30%
Quality of Life
28%
Febrile Seizure
28%
Benign Childhood Epilepsy
28%
Drug Therapy
24%
Pediatric Neurology
20%
Epileptic Absence
20%
Pediatric Epilepsy
18%
Rolandic Epilepsy
18%
Severe Myoclonic Epilepsy of Infancy
18%
Epilepsy Syndromes
17%
Ceroid
16%
Intractable Epilepsy
14%
Adolescent
14%
Disease
14%
Pain
12%
Recurrent Disease
12%
Status Epilepticus
12%
Pain Assessment
12%
Partial Seizure
12%
Oxygen Saturation
11%
Tonic-Clonic Seizure
10%
Lafora Disease
10%
Neurology
10%
Disease Course
10%
Intellectual Disability
9%
Epilepsy in Children
9%
Phenobarbital
9%
Phenylketonuria
9%
Health Care Provider
9%
Scoring System
9%
Infantile Spasm
9%
Sudden Unexpected Death in Epilepsy
8%
Neonatal Intensive Care Unit
7%
Epilepsy
7%
Complex Partial Seizure
7%
Placebo
7%
Seizure Types
7%
Faintness
6%
Checklist
6%
Neurologic Disease
6%
Symptom
6%
Learning Disorder
6%
Prevalence
6%
Cohort Analysis
6%
Physical Examination
6%
Anodyne
5%
Health Care
5%
Pharmacology, Toxicology and Pharmaceutical Science
Anticonvulsive Agent
76%
Remission
45%
Benign Childhood Epilepsy
44%
Febrile Convulsion
40%
Recurrent Disease
24%
Pharmacotherapy
24%
Syndrome
20%
Intractable Epilepsy
20%
Disease
18%
Agrotis
15%
Myoclonus Epilepsy
15%
Phenobarbital
13%
Carbamazepine
13%
Tonic Clonic Seizure
13%
Symptom
11%
Severe Myoclonic Epilepsy in Infancy
10%
Prospective Study
9%
Prevalence
9%
Placebo
9%
Focal Epilepsy
9%
Apnea
9%
Ceroid
9%
Side Effect
8%
Childhood Absence Epilepsy
8%
Epilepsy
7%
Adverse Event
6%
Anticonvulsant Therapy
6%
Epileptic State
6%
Antipyretic Agent
6%
Epileptic Absence
6%
Diazepam
5%
Benzodiazepine
5%
Injury
5%
Sudden Infant Death Syndrome
5%
Recurrence Risk
5%
Rolandic Epilepsy
5%
Monotherapy
5%
Behavioral Effect
5%
Clobazam
5%
Keyphrases
Childhood Epilepsy
48%
Epilepsy
36%
Seizure
25%
Febrile Seizures
20%
Remission
19%
Child Pain
15%
Non-communicable
15%
Phenobarbital
14%
Population-based Study
14%
Nova Scotia
13%
Ceroid
12%
Neurological Impairment
11%
Antiepileptic Treatment
11%
Health-related Quality of Life
10%
Batten
10%
Antiepileptic Drugs
10%
Pain Behavior
10%
Carbamazepine
10%
Pediatric Epilepsy
9%
Anticonvulsant Therapy
8%
Seizure-free
8%
Population-based
8%
Social Outcomes
8%
Generalized Tonic-clonic Seizures
8%
Psychometric Properties
7%
Quality of Life
7%
Observational Pain Scale
7%
Seizure Control
7%
Antipyretic
7%
Pediatric Neurologist
7%
Epilepsy in children
6%
Epilepsy Treatment
6%
Cryptogenic Epilepsy
6%
Transition Clinic
6%
Epilepsy Syndrome
6%
Intractable Seizures
6%
Healthcare Professionals
6%
Intractable Epilepsy
6%
Canada
6%
Generalized Seizures
6%
Generalized Epilepsy
6%
Brain Injury
5%
Epilepsy Diagnosis
5%
Severe Cognitive Impairment
5%
Intellectual Disability
5%
Placebo
5%
Success Probability
5%
Benign Epilepsy
5%
Anticonvulsant
5%
Caregivers
5%
